When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 32 Hits
  • Search Condition : Filter (MeSH = Colorectal Neoplasms / pathology)
Species Resource
DNA material pp53-Box RE-TK hRluc(F) (RDB05593) RNF43 interacts with NEDL1 and regulates p53-mediated transcription.
DNA material CSII-EF-MCS (RDB04378) RFPL4A increases the G1 population and decreases sensitivity to chemotherapy in human colorectal cancer cells.
DNA material CSII-EF-MCS (RDB04378) Cell cycle-dependent Rho GTPase activity dynamically regulates cancer cell motility and invasion in vivo.
DNA material mST6GalNACI (RDB02092) Cloning and expression of a human gene encoding an N-acetylgalactosamine-alpha2,6-sialyltransferase (ST6GalNAc I): a candidate for synthesis of cancer-associated sialyl-Tn antigens.
Human and Animal Cells LoVo(RCB1639) , HCT116(RCB2979) Inhibition of Ubiquitin-conjugating Enzyme E2 May Activate the Degradation of Hypoxia-inducible Factors and, thus, Overcome Cellular Resistance to Radiation in Colorectal Cancer.
Human and Animal Cells PANC-1(RCB2095) The G2 checkpoint inhibitor CBP-93872 increases the sensitivity of colorectal and pancreatic cancer cells to chemotherapy.
Human and Animal Cells Ca9-22(RCB1976) Comparison of gene expression profiles of gingival carcinoma Ca9-22 cells and colorectal adenocarcinoma HT-29 cells to identify potentially important mediators of SLPI-induced cell migration.
Human and Animal Cells HCT116(RCB2979) CRMP5-associated GTPase (CRAG) Is a Candidate Driver Gene for Colorectal Cancer Carcinogenesis.
Human and Animal Cells Elisidepsin Interacts Directly with Glycosylceramides in the Plasma Membrane of Tumor Cells to Induce Necrotic Cell Death.
Human and Animal Cells MKN74(RCB1002) Efficacy of Combination Chemotherapy Using a Novel Oral Chemotherapeutic Agent, TAS-102, with Oxaliplatin on Human Colorectal and Gastric Cancer Xenografts.
Human and Animal Cells Novel combination treatment for colorectal cancer using Nek2 siRNA and cisplatin.
Human and Animal Cells CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer.
Human and Animal Cells ZIC1 is downregulated through promoter hypermethylation, and functions as a tumor suppressor gene in colorectal cancer.
Human and Animal Cells CD44v6 expression is related to mesenchymal phenotype and poor prognosis in patients with colorectal cancer.
Human and Animal Cells Statins inhibit tumor progression via an enhancer of zeste homolog 2-mediated epigenetic alteration in colorectal cancer.
Human and Animal Cells HeLa (RCB0007) β-catenin inhibits promyelocytic leukemia protein tumor suppressor function in colorectal cancer cells.
Human and Animal Cells MKN74 (RCB1002) In vitro evaluation of histone deacetylase inhibitors as combination agents for colorectal cancer.
Human and Animal Cells Aberrant methylation of GCNT2 is tightly related to lymph node metastasis of primary CRC.
Human and Animal Cells Oncolytic virotherapy with an HSV amplicon vector expressing granulocyte-macrophage colony-stimulating factor using the replication-competent HSV type 1 mutant HF10 as a helper virus.
Human and Animal Cells Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer.